Marvulli, R., Ianieri, G., Devenuto, G., Falcicchio, M., Gallo, G.A., Mennuni, C., Gallone, M.F., Fiore, P., Maurizio, R. and Megna, M. (2020) Electrophysiological and Clinical Improvement in Non-Invasive Treatment of Carpal Tunnel Syndrome. Endocrine, Metabolic & Immune Disorders—Drug Targets, 21, 345-351.
https://doi.org/10.2174/1871530320666200728152953

has been cited by the following article:

• TITLE: Improvement in Early Recovery after Endoscopic Carpal Tunnel Surgery with the NeuroGen Nerve Support Supplement

  AUTHORS: Michael J. Fitzmaurice

  KEYWORDS: Endoscopic, ECTR, Carpal Tunnel, Nerve Supplement, Nerve, Supplement, BCTQ

  JOURNAL NAME: Modern Plastic Surgery, Vol.12 No.2, February 10, 2022

  ABSTRACT: Several papers have identified supplements that may relieve symptoms of carpal tunnel syndrome and improve recovery when carpal tunnel surgery is required. 64 patients with clinically and electromyographically confirmed carpal tunnel syndrome were enrolled in a prospective study to evaluate the effectiveness of a nerve supplement on patient rated outcome assessment after carpal tunnel surgery. All the patients underwent endoscopic carpal tunnel surgery. 18 patients also took the NeuroGen nerve supplement as part of their perioperative treatment. Both groups demonstrated a statistically significant improvement in BCTQ (both symptoms and function) at 2 weeks follow up. The supplement group demonstrated a statistically significant difference in improvement on the BCTQ (both symptoms and function) compared to the control group without the supplement. The NeuroGen nerve supplement appears to improve recovery on both the symptoms and function component of the BCTQ after endoscopic carpal tunnel surgery within 2 weeks.